SLC30A8 promoter hypermethylation is associated with type 2 diabetes and diabetic kidney disease in a Chinese population

doi:10.4239/wjd.v17.i3.113947

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 3

This Article

(30)

(27)

(0)

(530)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Diabetes. Mar 15, 2026; 17(3): 113947
Published online Mar 15, 2026. doi: 10.4239/wjd.v17.i3.113947

Full Size Figure Download Figure

Figure 1 Association of solute carrier family 30 member 8 promoter hypermethylation with both type 2 diabetes and diabetic kidney disease. A: Solute carrier family 30 member 8 promoter methylation levels in the groups of non-diabetic control, newly diagnosed type 2 diabetes, type 2 diabetes and diabetic kidney disease; B: DNA methylation levels at six CpG sites of solute carrier family 30 member 8 promoter region. T2D: Type 2 diabetes; DKD: Diabetic kidney disease.

Citation: Li N, Li YP, Xu Q, Xu J, Yu YH, Su J, Shen C, Yu JY, Gu HF. SLC30A8 promoter hypermethylation is associated with type 2 diabetes and diabetic kidney disease in a Chinese population. World J Diabetes 2026; 17(3): 113947
URL: https://www.wjgnet.com/1948-9358/full/v17/i3/113947.htm
DOI: https://dx.doi.org/10.4239/wjd.v17.i3.113947

Li N, Li YP, Xu Q, Xu J, Yu YH, Su J, Shen C, Yu JY, Gu HF. SLC30A8 promoter hypermethylation is associated with type 2 diabetes and diabetic kidney disease in a Chinese population. World J Diabetes 2026; 17(3): 113947 [DOI: 10.4239/wjd.v17.i3.113947]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.